- No animal testing required
- Combines and compares the widely accepted models
- Predicts skin sensitisation hazard and potency
- Interprets the results
Weight of evidence approach - SaferSkin™ brings together validated in vitro key event assays, physical-chemical properties and in silico models.
Based on OECD defined and industry tested approaches, SaferSkin™ assesses input data and assigns a sensitisation category and the level of confidence in the prediction.
Bring the state-of-the-art science to your workflows for the entire discovery funnel.
SaferSkin™ is an effective way to predict skin sensitisation from early discovery and development through regulatory review and registration.